CRH and synucleinopathy: However, because this decrease is not limited to synucleinopathies and it does not occur when comparing SAA− to SAA+ Alzheimer’s disease/frontotemporal dementia/vascular dementia, dopaminergic dysfunction may instead be the cause of CRH decrease, which in turn could be associated to the stress and inflammatory aspect of these diseases.